US Stock MarketDetailed Quotes

OKYO OKYO Pharma

Watchlist
  • 1.490
  • -0.010-0.67%
Close Mar 28 16:00 ET
  • 1.540
  • +0.050+3.36%
Post 16:13 ET
49.52MMarket Cap-2865P/E (TTM)

About OKYO Pharma Company

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.

Company Profile

SymbolOKYO
Company NameOKYO Pharma
Issue Price4.00
Founded2007
CEODr. Gary S. Jacob, PhD
MarketNASDAQ
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address107 Cheapside,9th Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeEC2V 6DN
Phone44-20-7495-2379

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gary S. Jacob, PhD
  • Chief Executive Officer and Director
  • 783.00K
  • Dr. Raj Patil
  • Chief Scientific Officer
  • --
  • Keeren Shah
  • Chief Financial Officer
  • --
  • Gabriele Marco Antonio Cerrone
  • Chairman of the Board
  • 445.00K
  • John Patrick Brancaccio
  • Independent Director
  • 63.00K
  • Bernard F. Denoyer
  • Independent Director
  • 44.00K
  • Willy Jules Simon
  • Senior Independent Director
  • 49.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg